[Effect of heparin, aggregation inhibitors and vasoactive substances on chronic-obliterative vascular diseases].
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000925:Anticoagulants; D014665:Vasodilator Agents; D006493:Heparin
Einfluss von Heparin, Aggregationshemmern und vasoaktiven Substanzen auf chronisch-obliterierende Gefässerkrankungen